2017 Award Recipients
Charles Austin Award for Outstanding Service in Prostate Cancer Awareness
Jack Colbert Memorial Award
Beth Israel Deaconess Medical Center Brigham and Women's Hospital Dana-Farber Cancer Institute David Godkin Garth and Lindsay Greimann Massachusetts Prostate Cancer Coalition Allen L. Snyder III
EDUCATIONAL GRANTS AdMeTech Foundation Cancer Research Foundation / ZERO Million Dollar Roundtable (MDRT) Foundation
7:30AM Registration and Breakfast
8:00 Panel on Prevention and Screening Prostate cancer is one of the few cancers that we know how to detect early (via PSAtesting) and prevent (with drugs like finasteride). Yet it is far from clear that doing so does more good than harm: PSAtesting has led to massive over diagnosis and overtreatment, and prevention has not become widespread due to concerns that finasteride lowers the risk of indolent, but not aggressive, disease. The panel will focus on how to ensure that we practice medicine in such a way to maximize benefits and minimize harms of prostate cancer screening and prevention. Peter C. Albertsen, MD, J. Jacques Carter, MD, Marc B. Garnick, MD, Andrew Vickers, Ph.D., moderator 9:45 Panel on Active Surveillance and Early Stage Disease Active surveillance has become widely utilized for low-risk prostate cancer and has evolved significantly over the last two decades. However, many important questions and controversies remain. Can we define the molecular events that signal "progression" of low-grade disease? How to optimally identify the "wolves in sheep's dothinq'Le., those men who benefit from early treatment? How best to integrate MRI and biomarkers into treatment decision making? Which intermediate risk patients are candidates for surveillance? What interventions (diet, exercise, micronutrients, pharmacologic agents) are warranted to reduce the risk of biological progression? What is the most efficient and cost-effective way to follow patients longitudinally? Is serial biopsy still required, and in whom? Clair J. Beard, MD, Adam S. Kibei, MD, Eric A. Klein, MD, laurence Klotz, MD, moderator; Clare M. Tempany, MD
Peter (. Albertsen, MD is professor of surgery and division chief, program director at the University of Connecticut Health Center in Farmington, CT.He is a trustee of the American Board of Urology. Clair J. Beard, MD is associate professor of
radiation oncology at Harvard Medical School and vice chair of genitourinary radiation oncology at Dana-Farber Cancer Institute. She is on staff at Brigham and Women's Hospital. J. Jacques Carter, MD, MPH is on the staff of
the Beth Israel Deaconess Medical Center and the medical director of the Prostate Cancer Screening and Education Program at the Dana-Farber Cancer Institute. He is the 2015 recipient of the Jack Colbert Memorial Award. 2012 KEYNOTE
Marc B. Garnick, MD is on staff at Beth Israel
Deaconess Medical Center and the Gorman Brothers Professor of Medicine at Harvard Medical School. He is the 2017 recipient of the Jack Colbert Memorial Award.
11:00 Break Adam S. Kibei, MD is chief of Urologic Surgery at
11 :15 Presentation of Austin and Colbert Awards Charles Austin Award presented to Fran and Stan Klein. Jack Colbert Memorial Award presented to Marc Garnick, MD.
Brigham and Women's Hospital and Disease Center Leader (Urology) at Dana-Farber Cancer Institute. He is also a professor of surgery at Harvard Medical School.
11 :30 Panel on Metastatic Disease and Research Metastatic prostate cancer is the second-leading cause of cancer-related death among men in the United States, responsible for more than 25,000 deaths per year. While the disease remains incurable, meaningful strides have been made recently in its treatment and in understanding of prostate cancer biology. One important revelation is the importance of androgen signaling even after the disease proves refractory to first-line hormonal therapy. This has led to development of effective new agents that form the backbone of modern treatment. Further discoveries in the areas of radiopharmaceuticals, immunotherapy and targeted therapy based on tumor genetics are broadening the prostate cancer armamentarium. The panel will focus on the latest developments in management of advanced prostate cancer. William G. Nelson, MD, Susan F. Siovin, MD, Mary-Ellen Taplin, MD, moderator
1 :OOPM Closing
Eric A. Klein, MD is chairman of the Glickman
Urological and Kidney Institute at the Cleveland Clinic. He is an international leader in the biology and management of prostate cancer.
Panelists subject to change.
Prostate Cancer Coalition
(MPCC) educates, connects, and supports men-at-risk, newly diagnosed individuals, survivors, and their families. It also connects organizations and professionals in Massachusetts that seek to conquer and cure prostate cancer.
Symposium Presenters 2007 KEYNOTE
Laurence Klotz, MD is past chief of urology at Sunnybrook Health Sciences Centre and a professor of surgery at the University ofToronto. He is chairman of the World Urological Oncology Federation and the associate editor of the Journal of Urology, responsible for prostate cancer. 2006 KEYNOTE
William G. Nelson, MD, Ph.D. is the Marion I. Knott Director and professor of oncology and director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is the co-discoverer of the most common genome alteration in prostate cancer. 2008 KEYNOTE
Susan F. Siovin, MD, Ph.D. is a medical oncologist at Memorial Sloan Kettering Cancer Center, specializing in bladder and prostate cancer.
20th Anniversary Massachusetts Prostate Cancer Symposium PLEASE REGISTER BY MAY 1, 2017 MAILyour completed registration form to: MPCC,c/o Green Associates, 200 Lincoln St., #201, Boston, MA02111 FAX:617.482.3049 ONLINEATwww.masspcc.org For more information, call617 .482.3044 x28 or email [email protected]
REGISTRATION INFORMATION Name
Mary-Ellen Taplin, MD is chair of the Executive Committee for Clinical Research, director of Clinical Research, Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute and an associate professor of medicine at Harvard Medical School. Claire M. Tempany, MD is professor of radiology at Harvard Medical School and Ferenc Jolesz Chair of Research, Radiology at Brigham and Women's Hospital. Her major areas of research interest are MR imaging of the pelvis (specifically prostate cancer) and image-guided therapy. 2016 KEYNOTE
Andrew Vickers, Ph.D. is attending research methodologist at Memorial Sloan Kettering Cancer Center. His research falls into three broad areas: randomized trials, surgical outcomes research, and molecular marker studies. A particular focus of his work is the detection and initial treatment of prostate cancer.
DYes, I/we want to attend the 20th Anniversary Massachusetts Prostate Cancer Symposium on Friday, May 12, 2017 at the Boston Marriott Copley Place. There is no fee for the Symposium or breakfast, but attendees are invited to make voluntary contributions of $25 to partially underwrite the symposium costs.
o $25 for breakfast (optional) o $60 (includes one-year membership o$ Other amount TOTAL $
o ENCLOSED IS MY CHECK: (Checks should be made payable to MPCCand mailed to the address above.)
o PLEASE CHARGE MY:
0 MC 0 VISA0 AMERICANEXPRESS
Print Name on Card
Gifts to the Massachusetts Prostate Cancer Coalition, a 501 (c)(3) public charity, may be tax deductible to the extent allowed by law. (MPCCTax10: 04-6946891)
Massachusetts Prostate Cancer Coalition EDUCATE
I INFORM I ADVOCATE
c/o Green Associates 200 Lincoln St., #201 Boston, MA 02111
assachusetts Prostate Cancer Coalition 2017 ANNIVERSARY SYMPOSIUM
Leading prostate cancer specialists provide up-to-date information on the latest in prostate cancer diagnosis, treatment and research - in user-friendly language!
20TH ANNIVERSARY MASSACHUSETTS PROSTATE CANCER SYMPOSIUM Friday, May 12, 2017 7:30 AM - 1:00 PM Boston Marriott Copley Place Boston, Massachusetts
assachusetts Prostate Cancer Coalition 2017 ANNIVERSARY SYMPOSIUM
Tania Barber, Caring Health Center Anita Christie, Massachusetts Department of Public Health Juan Cofield, New England Area Conference, NAACP Antonio Delesline, MOCHA Thomas Farrington, Prostate Health Education Network, Inc. (PHEN) Rep. Russell Holmes, Commonwealth of Massachusetts Philip Kantoff, MD, Memorial Sloan Kettering Cancer Center Toni McGuire, Edward M. Kennedy Community Health Center Myechia Minter-Jordan, MD, Dimock Street Community Health Center Bill Rodgers, Four-time winner of the Boston Marathon William Shipley, MD, Massachusetts General Hospital Faina Shtern, MD, AdMeTech Foundation Frederica Williams, Whittier Street Community Health Center